Clinical Trials on Rheumatic Disease

Total 382034 results

Johns Hopkins University

Completed

Health Outcomes in Rheumatoid Arthritis (HORA)

Rheumatoid Arthritis

United States
Indonesia University

Completed

Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Indonesia
Parker Research Institute
Oak Foundation; The Danish Rheumatism Association; Aase and Ejnar Danielsens... and other collaborators

Completed

Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial (RAHExercise)

Rheumatoid Arthritis

Denmark
Lawson Health Research Institute
University of Western Ontario, Canada; St. Joseph's Health Care London

Completed

Effects of Probiotics on Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Canada
Szeged University

Completed

T-cell Subsets in Rheumatoid Arthritis Patients on Long-term Anti-TNF or IL6-receptor-blocker Therapy

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Rheumatoid Arthritis

Egypt
Samsung Bioepis Co., Ltd.

Completed

A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Poland, United Kingdom
Samsung Bioepis Co., Ltd.

Completed

A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Lithuania, Poland
UCB Italy s.p.a.

Completed

Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis (SPEED)

Rheumatoid Arthritis

Italy
Swedish Orphan Biovitrum

Completed

Kineret in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Germany
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)

Rheumatoid Arthritis

Hungary, Portugal, Austria, United States, Argentina, Australia, Brazil, Canada, Czechia, Germany, Greece, Guatemala, Israel, Italy, Korea, Republic of, Lithuania, Mexico, New Zealand, Peru, Poland, Romania, Russian Federation, Spain, Taiwa... and more
Hoffmann-La Roche

Completed

TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment

Rheumatoid Arthritis

Belgium, Luxembourg
Hoffmann-La Roche

Completed

A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Brazil, United Kingdom, Canada, Argentina, Mexico, Austria, Israel, Colombia, Peru, Russian Federation, Philippines, Puerto Rico, Germany, Greece, Poland, Spain, France, Singapore, China, South Africa, Hungary, Denmark, Finlan... and more
Hoffmann-La Roche

Completed

A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

Rheumatoid Arthritis

United States, Italy, United Kingdom, Austria, France, Germany, Canada, Argentina, Belgium, Croatia, Bosnia and Herzegovina, Latvia, Spain, Hungary, Czechia, Malaysia, Russian Federation, Serbia, Israel, Poland, Turkey, Netherlands, Greec... and more
Sanofi
Regeneron Pharmaceuticals

Completed

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients (RA-MOBILITY)

Rheumatoid Arthritis

Germany, Hungary, Belgium, United States, Argentina, Australia, Austria, Belarus, Brazil, Canada, Chile, Czechia, Estonia, Finland, Greece, Korea, Republic of, Lithuania, Malaysia, Mexico, New Zealand, Philippines, Poland, Romania, Russian... and more
Hoffmann-La Roche

Completed

A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis (OSCAR)

Rheumatoid Arthritis

Netherlands
UCB Celltech
PRA Health Sciences

Completed

Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Czechia, Hungary, Moldova, Republic of, Poland, Russian Federation, Slovakia, United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

Rheumatoid Arthritis
Carmel Medical Center

Completed

Tocilizumab Effect on microRNA Expression and Adipokine Levels in Rheumatoid Arthritis Patients

Rheumatoid Arthritis
University of Glasgow

Completed

Walk for Rheumatoid Arthritis (WARA Study)

Rheumatoid Arthritis

United Kingdom
Novartis Pharmaceuticals

Completed

A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.

Rheumatoid Arthritis

Austria, United Kingdom, Canada, Finland
Selmin Gulbahar

Completed

Is Fluidotherapy Effective in Rheumatoid Hand?

Rheumatoid Arthritis
Merck Sharp & Dohme LLC
Integrated Therapeutics Group

Terminated

Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3) (Re³)

Rheumatoid Arthritis
Chinese SLE Treatment And Research Group
CHENLIJI Pharmaceutical Company,Guangzhou Pharmaceutical Group; CHINESE RHEUMATISM...

Unknown

Kunxian for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

China
Janssen-Cilag, S.A.

Terminated

Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab (Go-Compl-Ar)

Rheumatoid Arthritis

Colombia
Brigham and Women's Hospital
Abbott

Completed

The Health Log: A Randomized Clinical Trial

Rheumatoid Arthritis

United States
Bristol-Myers Squibb

Completed

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy

Rheumatoid Arthritis

United Kingdom
Hoffmann-La Roche

Completed

ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Italy
Merck KGaA, Darmstadt, Germany

Completed

Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III) (August III)

Rheumatoid Arthritis

Sweden, France, Netherlands, United Kingdom
Hoffmann-La Roche

Completed

A Study on Rheumatoid Arthritis Patients Treated With Rituximab

Rheumatoid Arthritis

Finland
Pfizer

Completed

Good EULAR Response In Patients With Early Rheumatoid Arthritis (EARLY RA)

Rheumatoid Arthritis

Greece
Hoffmann-La Roche

Completed

A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Completed

An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With Glucocorticoids

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Withdrawn

A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)

Rheumatoid Arthritis
Hoffmann-La Roche
Clalit Health Services

Completed

A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS

Rheumatoid Arthritis

Israel
Hoffmann-La Roche

Completed

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926

Rheumatoid Arthritis

Macedonia, The Former Yugoslav Republic of
Hoffmann-La Roche

Completed

A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

Spain, China, United States, France, Sweden, South Africa, Czech Republic, Australia, Germany, Russian Federation, Canada, Thailand, Mexico, Hong Kong, Brazil, Argentina, Panama, Costa Rica, Finland
Hoffmann-La Roche

Completed

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.

Rheumatoid Arthritis

Russian Federation
Hoffmann-La Roche

Terminated

An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)

Rheumatoid Arthritis

Romania
Hoffmann-La Roche

Completed

An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Lebanon
Hoffmann-La Roche

Completed

A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Czech Republic, France, Italy, Spain, Canada, United States, Mexico, South Africa, Taiwan, Croatia, Serbia, Romania
Genentech, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, United States, Germany, Hungary, Bulgaria, Mexico, Peru, Chile, Romania, Spain
Hoffmann-La Roche

Completed

An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)

Rheumatoid Arthritis

Hungary
Hoffmann-La Roche

Completed

An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Greece
Hoffmann-La Roche
Roche Products Pty Ltd (Australia)

Completed

A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia

Rheumatoid Arthritis

Australia
SetPoint Medical Corporation

Unknown

Long Term Extension Study For SPM-005 Participants

Rheumatoid Arthritis

Netherlands, Bosnia and Herzegovina, Croatia
Hoffmann-La Roche

Completed

An Observational Study of RoActemra/Actemra (Tocilizumab) As Monotherapy in Rheumatoid Arthritis Patients in Routine Clinical Practice (ACT SOLO)

Rheumatoid Arthritis

France
Hoffmann-La Roche

Completed

Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis (RITAM)

Rheumatoid Arthritis

Serbia
Hoffmann-La Roche

Completed

A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.

Rheumatoid Arthritis

Colombia, Mexico, Chile, Ecuador, Argentina, Brazil, Peru, Venezuela, Uruguay, El Salvador
Centre Hospitalier Universitaire de Nīmes
Pfizer

Completed

Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France

Rheumatoid Arthritis

3

Subscribe